Richard Philipson follows Renée Aguiar-Lucander to Hansa

Having appointed Renée Aguiar-Lucander as its chief executive in April and Maria Törnsén as chief operating officer a month later, Hansa Biopharma (Nasdaq Stockholm: HNSA) has announced the appointment of a chief medical officer (CMO).

Richard Philipson (pictured above), most recently CMO of recently-acquired Calliditas Therapeutics, has taken the same role at fellow Swedish firm Hansa, making the same move that Ms Aguiar-Lucander made earlier in the year.